Venturi Wealth Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
CPC
CWP
AR
DIM
PFS
CA
DT
TWM
JWCA
Venturi Wealth Management's HRTX Position: Q2 2026 in Review
Venturi Wealth Management held its Heron Therapeutics (HRTX) position steady in Q2 2026 at 10,500 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #630.
Venturi Wealth Management first reported a position in HRTX in Q1 2017 and has held it in 24 quarters since. The position peaked at $410K in Q2 2018. 15 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.
- Venturi Wealth Management held 10,500 shares of Heron Therapeutics worth $4.48K as of Q2 2026.
- Venturi Wealth Management left its Heron Therapeutics share count unchanged in Q2 2026.
- Heron Therapeutics made up ﹤0.01% of Venturi Wealth Management's portfolio in Q2 2026, its #630 holding.
- Venturi Wealth Management first reported a position in Heron Therapeutics in Q1 2017 and has held it in 24 quarters since.
- Venturi Wealth Management's Heron Therapeutics position peaked at $410K in Q2 2018.
- 15 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.
Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.